Chemistry:Dexclamol

From HandWiki

Dexclamol (AY 24169) was an investigational new drug developed by McKenna and Harrison, Ltd. that was evaluated as a antipsychotic.[1][2][3][4] It acts as a dopamine receptor antagonist.[1]

See also

References

  1. ↑ 1.0 1.1 "Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor". Molecular Pharmacology 11 (6): 833–840. November 1975. doi:10.1016/S0026-895X(25)10694-9. PMID 1239657. 
  2. ↑ Dictionary of Drugs. Springer US. 1990. doi:10.1007/978-1-4757-2085-3. ISBN 978-1-4757-2087-7. http://link.springer.com/10.1007/978-1-4757-2085-3. 
  3. ↑ "Dexclamol hydrochloride". Drugs of the Future 1 (8): 366. 1976. doi:10.1358/dof.1976.001.08.1002521. 
  4. ↑ Bruderlein FT, Humber LG, "Benzocycloheptaisoquinoline derivatives", US patent 3657250



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Dexclamol&oldid=4031118"